Stock comparison
AbbVie
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ABBV
AbbVie
Market cap
$381.1B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ABBV | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 57C | 69B | MTD |
| Benjamin Graham | 88A | 65B | ABBV |
| Philip Fisher | 58C | 63C | MTD |
| Peter Lynch | 30F | 66B | MTD |
| Joel Greenblatt | 41D | 68B | MTD |
| Charlie Munger | 64D | 74B | MTD |
| Terry Smith | 56D | 70B | MTD |
Side-by-side metrics
| Metric | ABBV | MTD |
|---|---|---|
| Market cap | $381.1B | $22.29B |
| P/E (TTM) | 103.6x | 25.3x |
| EV/EBIT | 21.8x | 21.6x |
| ROIC (TTM) | 10.29% | 36.09% |
| Gross margin | 73.46% | 57.79% |
| Net margin | 5.79% | 21.4% |
| Revenue CAGR 5y | 2.14% | 2.01% |
| EPS CAGR 5y | -22.23% | 6.12% |
| Debt / Equity | 2.6x | - |
| Dividend yield | 3.17% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ABBV leads on
- Dividend yield3.17%vs 0.0%+100%
- Market cap$381.1Bvs $22.29B+94%
- Gross margin73.46%vs 57.79%+21%
- Revenue CAGR 5y2.14%vs 2.01%+6%
MTD leads on
- EPS CAGR 5y6.12%vs -22.23%+128%
- Debt / Equity-vs 2.6x+105%
- P/E (TTM)25.3xvs 103.6x+76%
- Net margin21.4%vs 5.79%+73%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.